Organogenesis

$15.41 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Organogenesis

Organogenesis Holdings Inc. operates as a holding company. The Company, through its subsidiaries, focuses on development, manufacturing, and commercializing drugs and medicines for wound care, surgical, and sports medicine markets. Organogenesis Holdings serves customers in the United States and Switzerland.

Stock Analysis

last close $15.41
1-mo return -7.2%
3-mo return -27.7%
avg daily vol. 755.75T
52-week high 24.34
52-week low 3.36
market cap. $1.9B
forward pe 49.6
annual div. -
roe 44.7%
ltg forecast 44.5%
dividend yield -
annual rev. $379M
inst own. 25%
baraka

Subscribe now for daily local and international financial news

Subscribe